Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11010-012-1274-2PMID 22382638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone synthase (CYP11B2).

  2011cited by this paper
• Modulation of adrenal aldosterone release by oxidative modification of low-density lipoprotein.

  2010cited by this paper
• A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats

  2010cited by this paper
• Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones

  2010cited by this paper
• Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells.

  2009cited by this paper
• Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro.

  2009cited by this paper
• Endothelial factors mediate aldosterone release via PKA-independent pathways.

  2009cited by this paper
• Angiotensin II in type 2 diabetes mellitus.

  2009cited by this paper
• Aldosterone in salt-sensitive hypertension and metabolic syndrome

  2008cited by this paper
• Aldosterone and Metabolic Syndrome: Is Increased Aldosterone in Metabolic Syndrome Patients an Additional Risk Factor?

  2008cited by this paper
• Glycation as an atherogenic modification of LDL

  2008cited by this paper
• Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion.

  2008cited by this paper
• Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides

  2008cited by this paper
• New Mechanisms to Control Aldosterone Synthesis

  2008cited by this paper
• Cholesterol in islet dysfunction and type 2 diabetes.

  2008cited by this paper
• CD36 is a receptor for oxidized high density lipoprotein: Implications for the development of atherosclerosis

  2007cited by this paper
• Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties

  2007cited by this paper
• Aldosterone rapidly induces leukocyte adhesion to endothelial cells: a new link between aldosterone and arteriosclerosis?

  2007cited by this paper
• Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator–activator receptor γ gene expression in macrophages

  2007cited by this paper
• Improvement of insulin sensitivity by antagonism of the renin-angiotensin system.

  2007cited by this paper
• The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase

  2007cited by this paper
• Involvement of mitogen-activated protein kinases in class B scavenger receptor type I-induced phagocytosis of apoptotic cells.

  2006cited by this paper
• Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome

  2006cited by this paper
• Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

  2006cited by this paper
• Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

  2006cited by this paper
• The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients

  2006cited by this paper
• Extracellular signal-regulated kinases (ERK) 1, 2 are required for luteinizing hormone (LH)-induced steroidogenesis in primary Leydig cells and control steroidogenic acute regulatory (StAR) expression.

  2005cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• Hyperglycemia, Lipoprotein Glycation, and Vascular Disease

  2005cited by this paper
• Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study.

  2005cited by this paper
• Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide Published, JLR Papers in Press, April 21, 2004. DOI 10.1194/jlr.M300358-JLR200

  2004cited by this paper
• Reciprocal influences between the signalling pathways regulating proliferation and steroidogenesis in adrenal glomerulosa cells.

  2004cited by this paper
• Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update.

  2004cited by this paper
• Janus Kinase 2 and Calcium Are Required for Angiotensin II-dependent Activation of Steroidogenic Acute Regulatory Protein Transcription in H295R Human Adrenocortical Cells*

  2003cited by this paper
• Regulation of the scavenger receptor BI and the LDL receptor by activators of aldosterone production, angiotensin II and PMA, in the human NCI-H295R adrenocortical cell line.

  2003cited by this paper
• Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and 'selective' pathway connection.

  2003cited by this paper
• High Density Lipoprotein-induced Signaling of the MAPK Pathway Involves Scavenger Receptor Type BI-mediated Activation of Ras*

  2003cited by this paper
• Dynamics of reverse cholesterol transport: protection against atherosclerosis.

  2002cited by this paper
• In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance.

  2002cited by this paper
• Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas.

  2001cited by this paper
• Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomerulosa and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I.

  2001cited by this paper
• Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux.

  2000cited by this paper
• Circulating Oxidized Low Density Lipoprotein Levels: A Biochemical Risk Marker for Coronary Heart Disease

  2000cited by this paper
• Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells.

  1998cited by this paper
• STATs and gene regulation.

  1997cited by this paper
• Isolation, Characterization, and Metabolism of the Glycated and Nonglycated Subfractions of Low-Density Lipoproteins Isolated from Type I Diabetic Patients and Nondiabetic Subjects

  1995cited by this paper
• Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans.

  1995cited by this paper
• Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition.

  1995cited by this paper
• MAP kinase kinase kinase, MAP kinase kinase and MAP kinase.

  1994cited by this paper
• Conformational changes in oxidized LDL recognized by mouse peritoneal macrophages.

  1994cited by this paper
• Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol.

  1991cited by this paper
• Determination of carbonyl content in oxidatively modified proteins.

  1990cited by this paper
• A simple fluorometric assay for lipoperoxide in blood plasma.

  1976cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Lipoproteins and Aldosterone in Obesity-associated Hypertension

  2026cites this paper
• Genetic Insights Into Early-Onset Type 2 Diabetes Mellitus: The Role of SOST and LRP5 Genotypic Variants in Young Indians

  2025cites this paper
• HDL AND ITS SUBPOPULATION (HDL2 AND HDL3) PROMOTE CHOLESTEROL TRANSPORTERS EXPRESSION AND ATTENUATES INFLAMMATION IN 3T3-L1 MATURE ADIPOCYTES INDUCED BY TUMOR NECROSIS FACTOR ALPHA

  2022cites this paper
• Curcumin analog A13 alleviates oxidative stress by activating Nrf2/ARE pathway and ameliorates fibrosis in the myocardium of high-fat-diet and streptozotocin-induced diabetic rats

  2020cites this paper
• Understanding HDL: Overview

  2019cites this paper
• OLR1 scavenger receptor knockdown affects mitotic gene expression but is dispensable for oxidized phospholipid- mediated stress signaling in SZ 95 sebocytes.

  2017cites this paper
• Advanced glycation of high-density lipoprotein and the functionality of aldosterone release in type 2 diabetes

  2017cites this paper
• Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production.

  2017cites this paper
• Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma.

  2016cites this paper
• Crosstalk Between Glycoxidative Modification of Low-Density Lipoprotein, Angiotensin II-Sensitization, and Adrenocortical Aldosterone Release

  2015cites this paper
• Steroidogenesis-adrenal cell signal transduction.

  2014cites this paper
• Pressure Overload-Induced Cardiac Hypertrophy Response Requires Janus Kinase 2-Histone Deacetylase 2 Signaling

  2014cites this paper
• HYPERINSULINEMIA LEADS THE ELEVATION OF PLASMA ALDOSTERONE CONCENTRATION INDEPENDENTLY WITH OBESITY, DYSLIPIDEMIA, AND INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

  2014cites this paper
• Chapter 10 – Oxidized High-Density Lipoprotein: Friend or Foe

  2014cites this paper
• Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases.

  2013cites this paper
• Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI

  2013cites this paper
• Fission Yeast Nod1 Is a Component of Cortical Nodes Involved in Cell Size Control and Division Site Placement

  2013cites this paper